Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Catalyst Pharmaceuticals Inc (NASDAQ:CPRX)

1.15
Delayed Data
As of Sep 28
 -0.02 / -1.71%
Today’s Change
0.51
Today|||52-Week Range
3.68
-53.06%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$97.0M

Company Description

Catalyst Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on development and commercialization of prescription drugs targeting rare (orphan) neuromuscular and neurological diseases, including Lambert-Eaton Myasthenic Syndrome (LEMS), infantile spasms, and Tourette's disorder. The company was founded by McEnany J. Patrick and Huckel E. Hubert in January 2002 and is headquartered in Coral Gables, FL.

Contact Information

Catalyst Pharmaceuticals, Inc.
355 Alhambra Circle
Coral Gables Florida 33134
P:(305) 529-2522
Investor Relations:

Employees

Shareholders

Mutual fund holders--
Individual stakeholders--
Other institutional--

Top Executives

Patrick J. McEnanyChairman, President, CEO & Contact Person
Steven R. MillerChief Operating & Scientific Officer
Alicia GrandeChief Financial Officer, Treasurer & VP
Gary IngenitoChief Medical Officer
Brian ElsberndSenior Vice President-Legal & Compliance